CellaVision Future Growth
Future criteria checks 5/6
CellaVision is forecast to grow earnings and revenue by 23.6% and 13.4% per annum respectively. EPS is expected to grow by 23.6% per annum. Return on equity is forecast to be 23.9% in 3 years.
Key information
23.6%
Earnings growth rate
23.6%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 13.4% |
Future return on equity | 23.9% |
Analyst coverage | Low |
Last updated | 29 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,023 | 270 | 196 | 295 | 3 |
12/31/2025 | 889 | 217 | 161 | 251 | 4 |
12/31/2024 | 779 | 167 | 139 | 228 | 4 |
3/31/2024 | 708 | 141 | 168 | 249 | N/A |
12/31/2023 | 677 | 130 | 110 | 196 | N/A |
9/30/2023 | 629 | 112 | 60 | 148 | N/A |
6/30/2023 | 602 | 97 | 23 | 106 | N/A |
3/31/2023 | 616 | 99 | 38 | 118 | N/A |
12/31/2022 | 639 | 118 | 68 | 137 | N/A |
9/30/2022 | 651 | 126 | 93 | 155 | N/A |
6/30/2022 | 642 | 142 | 114 | 173 | N/A |
3/31/2022 | 594 | 135 | 87 | 171 | N/A |
12/31/2021 | 566 | 125 | 75 | 160 | N/A |
9/30/2021 | 532 | 114 | 62 | 139 | N/A |
6/30/2021 | 488 | 101 | 13 | 87 | N/A |
3/31/2021 | 471 | 98 | 44 | 82 | N/A |
12/31/2020 | 471 | 89 | 37 | 71 | N/A |
9/30/2020 | 490 | 85 | 40 | 71 | N/A |
6/30/2020 | 498 | 89 | 80 | 107 | N/A |
3/31/2020 | 492 | 92 | 68 | 90 | N/A |
12/31/2019 | 462 | 99 | 107 | 126 | N/A |
9/30/2019 | 423 | 104 | 94 | 114 | N/A |
6/30/2019 | 412 | 104 | 87 | 107 | N/A |
3/31/2019 | 391 | 97 | 98 | 119 | N/A |
12/31/2018 | 365 | 89 | 51 | 74 | N/A |
9/30/2018 | 330 | 76 | 67 | 91 | N/A |
6/30/2018 | 307 | 67 | 52 | 77 | N/A |
3/31/2018 | 294 | 63 | 41 | 69 | N/A |
12/31/2017 | 309 | 70 | N/A | 88 | N/A |
9/30/2017 | 306 | 70 | N/A | 93 | N/A |
6/30/2017 | 313 | 78 | N/A | 89 | N/A |
3/31/2017 | 300 | 75 | N/A | 86 | N/A |
12/31/2016 | 265 | 60 | N/A | 76 | N/A |
9/30/2016 | 254 | 57 | N/A | 54 | N/A |
6/30/2016 | 260 | 66 | N/A | 80 | N/A |
3/31/2016 | 246 | 55 | N/A | 59 | N/A |
12/31/2015 | 239 | 53 | N/A | 88 | N/A |
9/30/2015 | 250 | 49 | N/A | 70 | N/A |
6/30/2015 | 223 | 30 | N/A | 49 | N/A |
3/31/2015 | 226 | 34 | N/A | 53 | N/A |
12/31/2014 | 217 | 31 | N/A | 40 | N/A |
9/30/2014 | 209 | 33 | N/A | 59 | N/A |
6/30/2014 | 207 | 36 | N/A | 47 | N/A |
3/31/2014 | 189 | 26 | N/A | 49 | N/A |
12/31/2013 | 180 | 19 | N/A | 27 | N/A |
9/30/2013 | 165 | 3 | N/A | 11 | N/A |
6/30/2013 | 156 | -1 | N/A | 9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: C26's forecast earnings growth (23.6% per year) is above the savings rate (0.7%).
Earnings vs Market: C26's earnings (23.6% per year) are forecast to grow faster than the German market (15.4% per year).
High Growth Earnings: C26's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: C26's revenue (13.4% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: C26's revenue (13.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: C26's Return on Equity is forecast to be high in 3 years time (23.9%)